Avricore Health Inc. (FRA:8VP1)
Germany
· Delayed Price · Currency is EUR 0.0275
+0.0025 (10.00%)
Last updated: Dec 2, 2025, 8:05 AM CET
Avricore Health Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 1.92 | 4.79 | 3.49 | 1.77 | 0.12 | 0.03 | Upgrade
|
| Revenue Growth (YoY) | -59.28% | 37.32% | 97.08% | 1339.95% | 271.81% | 0.09% | Upgrade
|
| Cost of Revenue | 1.09 | 2.91 | 2.28 | 1.31 | 0.09 | 0.2 | Upgrade
|
| Gross Profit | 0.84 | 1.88 | 1.2 | 0.46 | 0.03 | -0.16 | Upgrade
|
| Selling, General & Admin | 1.23 | 1.16 | 1.08 | 0.77 | 0.93 | 0.76 | Upgrade
|
| Amortization of Goodwill & Intangibles | 0 | 0 | 0 | 0 | 0.02 | - | Upgrade
|
| Operating Expenses | 1.64 | 1.7 | 1.79 | 1.11 | 1.45 | 0.89 | Upgrade
|
| Operating Income | -0.81 | 0.18 | -0.59 | -0.65 | -1.42 | -1.05 | Upgrade
|
| Interest Expense | - | - | - | - | -0.04 | -0.14 | Upgrade
|
| Interest & Investment Income | 0.01 | 0 | 0 | 0.01 | 0 | - | Upgrade
|
| Currency Exchange Gain (Loss) | 0 | -0.01 | -0.01 | 0 | -0 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.03 | -0.05 | -0.11 | -0.17 | -0.33 | -0.02 | Upgrade
|
| EBT Excluding Unusual Items | -0.82 | 0.13 | -0.7 | -0.82 | -1.78 | -1.21 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.03 | -0.03 | - | - | - | - | Upgrade
|
| Asset Writedown | -0.77 | -0.77 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | 0.01 | - | - | 0.08 | 0.03 | Upgrade
|
| Pretax Income | -1.63 | -0.67 | -0.7 | -0.82 | -1.71 | -1.17 | Upgrade
|
| Earnings From Continuing Operations | -1.63 | -0.67 | -0.7 | -0.82 | -1.71 | -1.17 | Upgrade
|
| Net Income | -1.63 | -0.67 | -0.7 | -0.82 | -1.71 | -1.17 | Upgrade
|
| Net Income to Common | -1.63 | -0.67 | -0.7 | -0.82 | -1.71 | -1.17 | Upgrade
|
| Shares Outstanding (Basic) | 101 | 100 | 100 | 98 | 93 | 60 | Upgrade
|
| Shares Outstanding (Diluted) | 101 | 100 | 100 | 98 | 93 | 60 | Upgrade
|
| Shares Change (YoY) | -2.08% | 0.76% | 1.74% | 5.67% | 53.20% | 27.82% | Upgrade
|
| EPS (Basic) | -0.02 | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 | Upgrade
|
| EPS (Diluted) | -0.02 | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 | Upgrade
|
| Free Cash Flow | -0.24 | 0.82 | -0.36 | -1.63 | -1.34 | -1.22 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | 0.01 | -0.00 | -0.02 | -0.01 | -0.02 | Upgrade
|
| Gross Margin | 43.48% | 39.29% | 34.53% | 25.83% | 24.85% | - | Upgrade
|
| Operating Margin | -41.91% | 3.74% | -16.80% | -36.96% | -1153.22% | -3175.64% | Upgrade
|
| Profit Margin | -84.73% | -13.98% | -20.12% | -46.27% | -1390.90% | -3554.24% | Upgrade
|
| Free Cash Flow Margin | -12.30% | 17.21% | -10.36% | -92.24% | -1090.74% | -3703.89% | Upgrade
|
| EBITDA | -0.58 | 0.62 | -0.17 | -0.47 | -1.4 | -0.93 | Upgrade
|
| EBITDA Margin | -30.08% | 12.90% | -4.99% | -26.61% | - | - | Upgrade
|
| D&A For EBITDA | 0.23 | 0.44 | 0.41 | 0.18 | 0.02 | 0.12 | Upgrade
|
| EBIT | -0.81 | 0.18 | -0.59 | -0.65 | -1.42 | -1.05 | Upgrade
|
| EBIT Margin | -41.91% | 3.74% | -16.80% | -36.96% | - | - | Upgrade
|
| Advertising Expenses | - | - | 0 | 0 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.